The new United States Patent and Trademark Office (USPTO) Claims and Continuations Rules have generated many questions from those who are actively involved in building intellectual property (IP) assets in the legal and corporate world. What follows are answers to client questions and those received during Foley’s Patent Nation Web Conference, “USPTO Director Jon Dudas and IP Professionals Discuss New USPTO Claims and Continuations Rules and Their Practical Implications.” The session was held on September 12, 2007. The responses include comments from:
- Jon W. Dudas, Under Secretary of Commerce for Intellectual Property, and Director of the USPTO
- Bob Bahr, Senior Patent Counsel, Office of the Deputy Commissioner for Patent Examination Policy, USPTO
- Courtenay Brinckerhoff, Steve Fox, Steve Maebius, Phil Kiko, and Simon Elliott, Foley
Read the complete article by clicking on the link below.
Author(s)
Related Insights
12 November 2024
Events
MEMA Original Equipment Suppliers Annual Conference 2024
Join Foley at the MEMA Original Equipment Suppliers Annual Conference on November 12-13.
05 November 2024
Health Care Law Today
Cancer Drugs: Clinical Trial Issues for Antibody Drug Conjugates (ADCs)/Antibody Therapeutics
Antibody Drug Conjugates (ADCs) are a class of small molecule drugs and an antibody conjugated together by a chemical linker.
05 November 2024
Health Care Law Today
New HCPCS for Advanced Primary Care Management
The Center for Medicare & Medicaid Services issued the display copy of the final Calendar Year 2025 Physician Fee Schedule on November 1, 2024, which included three new Healthcare Common Procedure Coding System codes for advanced primary care management.